Physicians East

The trials here

What the 8 trials at this site are about, from their registry records.

Conditions

• Type 2 diabetes6 trials
• Type 1 diabetes3 trials
• Obesity2 trials
• Cushing's syndrome1 trial

Phase

• Phase 22 trials
• Phase 31 trial

Status

• Completed5 trials
• Active, not recruiting2 trials
• Recruiting1 trial

Lead sponsor

• Medtronic MiniMed, Inc.3 trials
• Amgen2 trials
• Insulet Corporation1 trial
• Senseonics, Inc.1 trial
• Sparrow Pharmaceuticals1 trial

Running trials

• Recruiting

  Trial Against INtractable Type 2 Diabetes (CAPTAIN-T2D)

  NCT07296484· Phase 2· Sparrow Pharmaceuticals· Source

  Contact: Kristen Manager

• Active, not recruiting

  Efficacy and Safety of Maridebart Cafraglutide in Adult Participants With Type 2 Diabetes Mellitus Who Have Obesity or Are Overweight

  NCT06858878· Phase 3· Amgen· Source

• Active, not recruiting

  A Study of Maridebart Cafraglutide in Adult Participants With Type 2 Diabetes Mellitus (T2DM)

  NCT06660173· Phase 2· Amgen· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Cushing's syndrome1 recruiting
• Type 2 diabetes1 recruiting

Closed trials

• Completed

  OP5-005 Using Omnipod 5 in Adults With Type 2

  NCT05815342· Insulet Corporation· Source

• Completed

  Evaluation of the Advanced Hybrid Closed Loop (AHCL) System in Type 1 Adults and Pediatrics Utilizing Lyumjev®

  NCT05325294· Medtronic MiniMed, Inc.· Source

• Completed

  Evaluation of the MiniMed™ 780G System in Type 1 Adult and Pediatric Subjects Utilizing Insulin Fiasp®

  NCT05224258· Medtronic MiniMed, Inc.· Source

• Completed

  In-Home Study With MiniMed™ 780G Pump Automated Control in Type 2-Evaluation of the AHCL System in Adults With Insulin-requiring Type 2 Diabetes

  NCT05238142· Medtronic MiniMed, Inc.· Source

• Completed

  Post Approval Study of the Eversense® Continuous Glucose Monitoring

  NCT03908125· Senseonics, Inc.· Source